Company intelligence / Profile preview

Pathway Bioventures

Ownership: Private
Development stage: Other

Overview

Pathway Bioventures is a seed-stage venture capital fund investing in early-stage life sciences companies developing next-generation precision therapeutics for unmet medical needs. They focus on genetic medicine and targeted therapies for molecularly defined patient populations.

Modalities: Gene therapyCell therapyOligonucleotide therapeuticsRNA and DNA editing therapiesSmall moleculeAntibodyAntibody-drug conjugate
Industry: Investors

Partnerships

Co-invests with top biotech VCs and pharma corporate venture arms

Beyond the preview

Go deeper on Pathway Bioventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathway Bioventures.

Explore the full profile